Globus Medical GMED United States — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's united states — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's united states — net sales?
- Globus Medical (GMED) reported united states — net sales of $604.89M in Q1 2026.
- How has Globus Medical's united states — net sales changed year-over-year?
- Globus Medical's united states — net sales increased by 25.0% year-over-year, from $483.86M to $604.89M.
- What is the long-term trend for Globus Medical's united states — net sales?
- Over 4 years (2021 to 2025), Globus Medical's united states — net sales has grown at a 30.4% compound annual growth rate (CAGR), from $819.57M to $2.37B.
- What does united states — net sales mean?
- The total revenue earned from all products sold within the United States.
- How do you interpret united states — net sales?
- An increase indicates successful market expansion, strong product demand, or effective sales execution, while a decrease may signal competitive pressure, market saturation, or reduced procedure volumes.
- How does united states — net sales compare across companies?
- Comparable to domestic revenue or regional net sales reported by other medical device and healthcare technology companies.